Luminex launches NxTAG Respiratory Pathogen Panel assay
The company said the device utilizes reagents that already have been pre-plated, which allows preparation for the detection process to be completed within minutes.
"We are excited to bring the RUO version of the NxTAG Respiratory Pathogen Panel to market," Luminex President and CEO Homi Shamir said. "Luminex introduced multiplexed respiratory panels to the clinical market in 2008, and our customers are anxiously awaiting a next-generation product that delivers expanded-panel coverage and a simple closed-tube workflow, combined with the throughput and quality of results established by the NxTAG Respiratory Viral Panel."
Currently, the device is undergoing clinical trials, and the company expects to submit the device for Food and Drug Administration approval by this summer.
The device uses a tubular strip design, giving laboratories management flexibility without wasting components or reagents in the system. From the time when samples are inserted to final results, it takes approximately three hours to process 96 samples; this does not include the extraction process for individual samples. The system also has an accompanying software solution to streamline the analysis process.